These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 30684524)
21. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma. Chen W; Li G; Li Z; Zhu J; Wei T; Lei J Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020 [TBL] [Abstract][Full Text] [Related]
23. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer. Yi W; Liu J; Qu S; Fan H; Lv Z Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579 [TBL] [Abstract][Full Text] [Related]
24. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma. Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer. Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696 [TBL] [Abstract][Full Text] [Related]
26. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma. Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252 [TBL] [Abstract][Full Text] [Related]
27. Identification of key genes and miRNAs markers of papillary thyroid cancer. Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611 [TBL] [Abstract][Full Text] [Related]
28. Circulating plasma microRNA signature for the diagnosis of cervical cancer. Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043 [TBL] [Abstract][Full Text] [Related]
30. Plasma microRNA signature of patients with IgA nephropathy. Wu J; Zhang H; Wang W; Zhu M; Qi LW; Wang T; Cheng W; Zhu J; Shan X; Huang Z; Zhang L; Chen Y; Sun B; Zhao X; Qian J; Zhu W; Zhou X; Xing C Gene; 2018 Apr; 649():80-86. PubMed ID: 29459010 [TBL] [Abstract][Full Text] [Related]
31. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer. Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030 [TBL] [Abstract][Full Text] [Related]
32. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma. He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297 [TBL] [Abstract][Full Text] [Related]
33. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma. Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863 [TBL] [Abstract][Full Text] [Related]
34. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling. Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999 [TBL] [Abstract][Full Text] [Related]
35. Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Huang Z; Zhu D; Wu L; He M; Zhou X; Zhang L; Zhang H; Wang W; Zhu J; Cheng W; Chen Y; Fan Y; Qi L; Yin Y; Zhu W; Shu Y; Liu P Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):188-196. PubMed ID: 27756776 [TBL] [Abstract][Full Text] [Related]
36. Identification of a four-microRNA panel in serum for screening renal cell carcinoma. Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264 [TBL] [Abstract][Full Text] [Related]
37. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules. Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X Front Genet; 2020; 11():449. PubMed ID: 32508877 [No Abstract] [Full Text] [Related]
38. From sequencing to validation: NGS-based exploration of plasma miRNA in papillary thyroid carcinoma. Cui W; Xuan T; Liao T; Wang Y Front Oncol; 2024; 14():1410110. PubMed ID: 39169938 [TBL] [Abstract][Full Text] [Related]
39. A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients. Zhang L; Shan X; Wang J; Zhu J; Huang Z; Zhang H; Zhou X; Cheng W; Shu Y; Zhu W; Liu P Oncotarget; 2017 Oct; 8(49):86897-86907. PubMed ID: 29156844 [TBL] [Abstract][Full Text] [Related]
40. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma. Li M; Song Q; Li H; Lou Y; Wang L PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]